# A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

> **NCT06559345** · PHASE2 · RECRUITING · sponsor: **The First Affiliated Hospital of Zhengzhou University** · enrollment: 276 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia, Pediatric

## Interventions

- **RADIATION:** TMLI
- **RADIATION:** TBI
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT06559345
- **Lead sponsor:** The First Affiliated Hospital of Zhengzhou University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-17
- **Primary completion:** 2029-07-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06559345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06559345, "A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06559345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*